Senti Biosciences is a Bay Area biotech company focused on outsmarting complex diseases with more intelligent medicines.

Senti Biosciences leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2016

• LUX Partners

  • Adam Goulburn

• Latest Tweets

  • Tune in with Senti's COO, Philip Lee, for his @ISCTglobal Virtual Presentation on our award-winning abstract tomor… https://t.co/9ZM41nMhbb@SentiBio - 04:14 PM May 27th
  • Join us this week at our virtual #ASGCT20 presentations for an opportunity to dive in with us on the potential of o… https://t.co/4d9EY9nf7i@SentiBio - 04:10 PM May 11th
  • We'll be presenting 3 abstracts at this year’s Virtual #ASGCT20. Join us for our virtual sessions on tumor-selectiv… https://t.co/gvpIJfTASH@SentiBio - 04:05 PM Apr 30th